Skin Tone Measurement Method Investigation for Pulse Oximetry
NCT ID: NCT05657665
Last Updated: 2023-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2023-02-06
2023-04-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of Hemoglobin Oxygenation With Third Harmonic Generation Microscopy
NCT03619356
Research and System Development on Functional 3D Optical Tomography for Skin Cell Imaging
NCT01557205
Automatic Early Melanoma Detection by Ultrahigh Resolution Three Dimensional Optical Coherence Tomography
NCT02335476
Association Between Peripheral Artery Stiffness and Cardiovascular Disease
NCT00201565
Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension
NCT00173537
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Briefly, these additional aspects that are evaluated in this study are listed below:
* operator bias
* impact of operator color blindness
* probe pressure
* probe aperture size
* device stability
* impact of blood on pigmentation measurement
* feasibility of skin tone measurement on sides of fingers
* intra-operator variability
PMMs included in this study are:
Subjective color matching methods by using:
1. Von Luschan color scale
2. Fitzpatrick color scale
3. Pantone color scale
Objective probe-based measurements by using:
1. Konica Minolta CM700d (reflectance spectrometer)
2. Mx18 (erythema-melanin meter)
3. SPA99 (erythema-melanin meter)
Measurements will be performed on 5 relatively light skinned, and 5 relatively dark skinned volunteers (N=10 in total\*). The study will be executed on the High-Tech Campus Eindhoven (Netherlands) and each participant will have 3 visits of approximately 1.5 to 2 hours/visit.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational measurements of skin tone
Objective and subjective skin tone measurements will be performed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Fluent in either English or Dutch
3. Participants who are willing and able to provide informed consent themselves.
4. People with Von Luschan scores \<18 ('light skin' group) or \> 25 ('dark skin' group).
Exclusion Criteria
* piercings/ink/henna tattoos that cover the left forearm, hands, fingers or forehead
* vascular or pigmentary or renal psoriasis
* epidermal bullosum
* other diseases that affect the skin (tone) of the body
* Currently displaying COVID-19-related symptoms, namely a fever, cough and/or difficulty breathing
* Having been positively tested as infected with COVID-19 in the past 14 days
* Travelled to or from high risk COVID-19 areas in the past 14 days
* Been in contact with a (suspected) COVID-infected person in the past 14 days
3. Not being able to travel to Eindhoven 3 times, and/or not being able to comply with the study procedures
4. Sunbathing during the study duration or substantial sun exposure (due to holidays for example).
5. Known allergic reaction to facial make-up
6. Usage of tanning sprays/cremes
7. Wearing make-up during the study visits (mascara is allowed)
* No testing will be performed in the study. Participants will be asked if they have been positively tested.
18 Years
66 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philips Electronics Nederland B.V. acting through Philips CTO organization
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
High Tech Campus
Eindhoven, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICBE-S-000880
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.